Craft

Jaguar Health

Stock Price

$1.1

2024-10-29

Market Capitalization

$10 M

2024-10-29

Revenue

$11.5 M

FY, 2025

Jaguar Health Summary

Company Summary

Overview
Jaguar Health is committed to bringing naturally derived important health solutions to all animals of the world, as proprietary pharmaceuticals, food additives, and nutraceuticals. Jaguar merges the high-value business model of companion and competitive animal care with the higher-volume economically driven business model applied to the food/farm animal marketplace. The Company's goal is to become a leading provider of first-in-class products that address unmet medical needs for the human market as well both the companion and production animal markets.
Type
Public
Status
Active
Founded
2013
HQ
San Francisco, CA, US | view all locations
Website
https://jaguar.health/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Lisa Conte

    Lisa Conte, Founder, Chief Executive Officer

    • Carol Lizak

      Carol Lizak, Chief Financial Officer

      • Steven King

        Steven King, Chief Sustainable Supply, Ethnobotanical Research and IP Officer

        • Pravin Chaturvedi

          Pravin Chaturvedi, Chair of Scientific Advisory Board, Acting Chief Scientific Officer

        LocationsView all

        2 locations detected

        • San Francisco, CA HQ

          United States

          Providian Financial Building, 201 Mission St #2375, San Francisco

        • San Francisco, CA

          United States

          200 Pine St Suite 400, San Francisco

        Jaguar Health Financials

        Summary Financials

        Revenue (Q1, 2026)
        $20.3M
        Gross profit (Q1, 2026)
        $19.1M
        Net income (Q1, 2026)
        $8.7M
        Cash (Q1, 2026)
        $7.3M
        EBIT (Q1, 2026)
        $10.2M
        Enterprise value
        $37.0M

        Footer menu